Juno being sued over leukemia drug study

Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.

The suit was filed this week in United States District Court for the Western District of Washington in Seattle.

The lawsuit arrives just as the company gained permission by the Food and Drug Administration to restart its study for the leukemia drug candidate. Shares of Juno jumped 16 percent to $32.20 in midday trading following that announcement late Tuesday.

© 2016 The Associated Press. All rights reserved.

Citation: Juno being sued over leukemia drug study (2016, July 13) retrieved 28 March 2024 from https://medicalxpress.com/news/2016-07-juno-sued-leukemia-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study of promising cancer treatment allowed to resume

0 shares

Feedback to editors